Logo Image
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Antibiotics Deconstructed
Clinical Forum Insights

Subscribe

  • News
  • Watch
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Vaccines in America|
Antibiotics Deconstructed|
Bench to Bedside With SIDP|
Antimicrobial Stewardship|
Hepatitis
Advertisement

Susie Lee, PharmD (student)

Advertisement

Articles by Susie Lee, PharmD (student)

New Flucelvax Quadrivalent Influenza Vaccine Approved by FDA

BySusie Lee, PharmD (student)
June 14th 2016

Sequirus recently announced that the US Food and Drug Administration (FDA) has approved Flucelvax Quadrivalent influenza vaccine.

Advertisement

Latest Updated Articles

  • New Flucelvax Quadrivalent Influenza Vaccine Approved by FDA
    New Flucelvax Quadrivalent Influenza Vaccine Approved by FDA

    June 14th 2016



Advertisement
Advertisement

Trending on Contagion Live

1

FAQ: Rising Rabies Exposure Calls PEP Decisions Back in Focus

2

Measles Update: October 2, 2026

3

Clinical Considerations for Measles: Presentation, Treatment, and Hospitalization

4

New IDSA/ESCMID S aureus Bacteremia Consensus Statements: a Risk Stratification Framework

5

On World Rabies Day, When to Seek Treatment, Clinical Considerations for Post Exposure Prophylaxis

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us